DK1367063T3 - Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf - Google Patents

Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf

Info

Publication number
DK1367063T3
DK1367063T3 DK03291931T DK03291931T DK1367063T3 DK 1367063 T3 DK1367063 T3 DK 1367063T3 DK 03291931 T DK03291931 T DK 03291931T DK 03291931 T DK03291931 T DK 03291931T DK 1367063 T3 DK1367063 T3 DK 1367063T3
Authority
DK
Denmark
Prior art keywords
perindopril
synthesis
pharmaceutically acceptable
acceptable salts
salts
Prior art date
Application number
DK03291931T
Other languages
Danish (da)
English (en)
Inventor
Claude Fugier
Thierry Dubuffet
Pascal Langlois
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1367063T3 publication Critical patent/DK1367063T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK03291931T 2003-07-31 2003-07-31 Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf DK1367063T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03291931A EP1367063B1 (fr) 2003-07-31 2003-07-31 Nouveau procédé de synthèse du perindopril et de ses sels pharmaceutiquement acceptables

Publications (1)

Publication Number Publication Date
DK1367063T3 true DK1367063T3 (da) 2006-12-27

Family

ID=29414890

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03291931T DK1367063T3 (da) 2003-07-31 2003-07-31 Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf

Country Status (28)

Country Link
US (1) US7358372B2 (ru)
EP (1) EP1367063B1 (ru)
JP (1) JP4263743B2 (ru)
KR (1) KR100798560B1 (ru)
CN (1) CN100404548C (ru)
AR (1) AR045151A1 (ru)
AT (1) ATE337332T1 (ru)
AU (1) AU2004261439B2 (ru)
BR (1) BRPI0413169A (ru)
CA (1) CA2533005C (ru)
CY (1) CY1105791T1 (ru)
DE (1) DE60307721T2 (ru)
DK (1) DK1367063T3 (ru)
EA (1) EA008685B1 (ru)
ES (1) ES2271498T3 (ru)
GE (1) GEP20094740B (ru)
HK (1) HK1096406A1 (ru)
MA (1) MA27911A1 (ru)
MX (1) MXPA06001243A (ru)
MY (1) MY139443A (ru)
NO (1) NO333957B1 (ru)
NZ (1) NZ544879A (ru)
PL (1) PL211892B1 (ru)
PT (1) PT1367063E (ru)
SI (1) SI1367063T1 (ru)
UA (1) UA80905C2 (ru)
WO (1) WO2005012333A2 (ru)
ZA (1) ZA200600479B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8604144A1 (es) * 1984-11-21 1986-01-16 Farmhispania Procedimiento para la obtencion del acido (2s, 3as, 7as)-1-((s)-1-etoxicarbonil-3-fenilpropil) alanil) exahidro-2-indolincarboxilico
FR2807431B1 (fr) * 2000-04-06 2002-07-19 Adir Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables
FR2827860B1 (fr) * 2001-07-24 2004-12-10 Servier Lab Nouveau procede de synthese de derives de l'acide (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxyline et application a la synthese du perindopril

Also Published As

Publication number Publication date
ATE337332T1 (de) 2006-09-15
WO2005012333A3 (fr) 2005-03-24
HK1096406A1 (en) 2007-06-01
MY139443A (en) 2009-10-30
DE60307721T2 (de) 2007-10-18
SI1367063T1 (sl) 2006-10-31
CA2533005C (fr) 2010-04-06
JP4263743B2 (ja) 2009-05-13
CN1826352A (zh) 2006-08-30
EA008685B1 (ru) 2007-06-29
KR20060032209A (ko) 2006-04-14
PT1367063E (pt) 2006-12-29
WO2005012333A2 (fr) 2005-02-10
DE60307721D1 (de) 2006-10-05
CY1105791T1 (el) 2011-02-02
AU2004261439A1 (en) 2005-02-10
ZA200600479B (en) 2007-05-30
BRPI0413169A (pt) 2006-10-03
JP2007526896A (ja) 2007-09-20
US20060183920A1 (en) 2006-08-17
CA2533005A1 (fr) 2005-02-10
NZ544879A (en) 2009-03-31
EP1367063A1 (fr) 2003-12-03
EA200600250A1 (ru) 2006-06-30
MA27911A1 (fr) 2006-05-02
MXPA06001243A (es) 2006-04-11
NO20060922L (no) 2006-02-24
AR045151A1 (es) 2005-10-19
CN100404548C (zh) 2008-07-23
GEP20094740B (en) 2009-07-27
UA80905C2 (en) 2007-11-12
ES2271498T3 (es) 2007-04-16
AU2004261439B2 (en) 2008-03-13
NO333957B1 (no) 2013-10-28
PL211892B1 (pl) 2012-07-31
KR100798560B1 (ko) 2008-01-28
EP1367063B1 (fr) 2006-08-23
PL379631A1 (pl) 2006-10-30
US7358372B2 (en) 2008-04-15

Similar Documents

Publication Publication Date Title
DK1268424T3 (da) Fremgangsmåde til syntese af perindopril og dets farmaceutisk acceptable salte
HK1089187A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
EG26629A (en) A new process for the synthesis of pyridopril and its pharmaceutically acceptable salts
DK1614687T3 (da) Fremgangsmåde til fremstilling af 1,3,4,5-tetrahydro-2H-3-benzazepin-2-onderivater og deres anvendelse ved syntese af ivabradin og farmaceutisk acceptable salte deraf
HK1089188A1 (en) Novel method of synthesising perindopril and the pharmaceutically- acceptable salts thereof
HK1096409A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
DK1753720T3 (da) Fremgangsmåde til fremstilling af perindopril og salte deraf
HK1096408A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
HK1095839A1 (en) Method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof
NO20050885L (no) Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre
DK1371659T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1321471T3 (da) Ny syntesefremgangsmåde til perindopril og farmaceutisk acceptable salte heraf
DK1348684T3 (da) Fremgangsmåde til syntese af (2S)-indolin-2-carboxylsyre og anvendelse heraf til syntese af perindopril
DK1403275T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1367063T3 (da) Fremgangsmåde til syntese af perindopril og farmaceutisk acceptable salte heraf
DK1511724T3 (da) Fremgangsmåde til fremstilling af thioalkylaminderivater
HK1096407A1 (en) Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof
DK1422236T3 (da) Syntesefremgangsmåde for perindopril og farmaceutisk acceptable salte heraf